Radon, smoking, and lung cancer: The need to refocus radon control policy

American Journal of Public Health

Volumn 103, Issue 3, 2013, Pages 443-447

  Lantz, Paula M ^a   Mendez, David ^b   Philbert, Martin A ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADON;

ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; ENVIRONMENTAL EXPOSURE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LUNG TUMOR; SMOKING; SMOKING CESSATION;

COST-BENEFIT ANALYSIS; ENVIRONMENTAL EXPOSURE; HEALTH POLICY; HUMANS; LUNG NEOPLASMS; PROGRAM EVALUATION; RADON; SMOKING; SMOKING CESSATION;

MLCS; MLOWN;

EID: 84874068294     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.300926     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA. Available at: http://www.cancer.org/Research/CancerFactsFigures/ CancerFactsFigures. Accessed September 6, 2010.
2. Lubin JH, Boice JD Jr, Edling C, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst. 1995;87(11):817-827.
3. Pavia M, Bianco A, Pileggi C, Angelillo IF. Metaanalysis of residential exposure to radon gas and lung cancer. Bull World Health Organ. 2003;81(10):732-738.
4. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ. 2005;330(7485):223-228.
5. Krewski D, Lubin JH, Zielinski JM, et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology. 2005;16(2):137-145.
6. Pawel DJ, Puskin JS. The U.S. Environmental Protection Agency's assessment of the risks for indoor radon. Health Phys. 2004;87(1):68-74.
7. Environmental Protection Agency. EPA Assessment of Risks From Radon in Homes. Washington, DC: Office of Radiation and Indoor Air; June 2003.
8. Environmental Protection Agency. A Citizen's Guide to Radon: The Guide to Protecting Yourself and Your Family From Radon. EPA 402/K-09/011; January 2009. Available at: http://www.epa.gov/radon/pdfs/citizensguide.pdf. Accessed March 1, 2012.
9. Lubin JH, Steindorf K. Cigarette use and the estimation of lung cancer attributable to radon in the United States. Radiat Res. 1995;141(1):79-85.
10. Lubin JH, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst. 1997;89(1):49-57.
11. Angell WJ. The U.S. radon problem, policy, program and industry: achievements, challenges and strategies. Radiat Prot Dosimetry. 2008;130(1):8-13.
12. Méndez D, Alshanqeety O, Warner KE, Lantz PM, Courant PN. The impact of declining smoking on radonrelated lung cancer in the United States. Am J Public Health. 2011;101(2):310-314.
13. National Academy of Sciences, Committee on Health Risks of Exposure to Radon. Health Effects of Exposure to Radon: BEIR VI. Washington, DC: National Academy Press; 1999.
14. Archer VE, Coons T, Saccomanno G, Hong DY. Latency and the lung cancer epidemic among United States uranium miners. Health Phys. 2004;87(5):480-489.
15. Baysson H, Tirmarche M, Tymen G, et al. Indoor radon and lung cancer in France. Epidemiology. 2004;15 (6):709-716.
16. Darby SC, Hill DC; European Collaborative Group on Residential Radon and Lung Cancer. Health effects of residential radon: a European perspective at the end of 2002. Radiat Prot Dosimetry. 2003;104(4):321-329.
17. Field RW, Krewski D, Lubin JH, et al. An overview of the North American residential radon and lung cancer case-control studies. J Toxicol Environ Health A. 2006;69 (7-8):599-631.
18. Krewski D, Lubin JH, Zielinski JM, et al. A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health. 2006;69(7):599-631.
19. Al-Zoughool M, Krewski D. Health effects of radon: a review of the literature. Int J Radiat Biol. 2009;85(1): 7-69.
20. Duckworth LT, Frank-Stromborg M, Oleckno WA, et al. Relationship of perception of radon as a health risk and willingness to engage in radon testing and mitigation. Oncol Nurs Forum. 2002;29(7):1099-1107.
21. Riesenfeld EP, Marcy TW, Reinier K, et al. Radon awareness and mitigation in Vermont: a public health survey. Health Phys. 2007;92(5):425-431.
22. Environmental Protection Agency. U.S. Homes Above EPA's Radon Action Level. Available at: http://cfpub.epa.gov/eroe/index.cfm?fuseaction=detail. viewPDF&ch=46&lShowInd=0&subtop=343&lv=list.listByChapter&r= 224027. Accessed September 6, 2010.
23. Puskin JS, Nelson CB. EPA's perspective on risks from residential radon exposure. JAPCA. 1989;39(7): 915-920.
24. Ford ES, Kelly AE, Teutsch SM, Thacker SB, Garbe PL. Radon and lung cancer: a cost-effectiveness analysis. Am J Public Health. 1999;89(3):351-357.
25. Denman AR, Phillips PS, Tornberg R. The costs and benefits of radon remediation programmes in existing homes: case study of action level selection. J Environ Radioact. 2002;62(1):17-27.
26. Denman AR, Groves-Kirby CJ, Phillips PS, Tornberg R. Using the European Community Radon Software to estimate the individual health benefits of a domestic radon remediation programme. J Radiol Prot. 2004;24(1): 83-89.
27. Denman A, Groves-Kirby C, Coskeran T, Parkinson S, Phillips P, Tornberg R. Evaluating the health benefits and cost-effectiveness of the radon remediation programme in domestic properties in Northamptonshire, UK. Health Policy. 2005;73(2):139-150.
28. Denman AR, Phillips PS, Tornberg R, Groves-Kirkby CJ. Analysis of the individual health benefits accruing from a domestic radon remediation programme. J Environ Radioact. 2005;79(1):7-23.
29. Briggs DJ, Denman AR, Gulliver J, et al. Time activity modeling of domestic exposures to radon. J Environ Manage. 2003;67(2):107-120.
30. Coskeran T, Denman A, Phillips P, Tornberg R. A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK. Health Policy. 2005;71(1):43-56.
31. Gray A, Read S, McGale P, Darby S. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. BMJ. 2009;338: a3110.
32. Stigum H, Strand T, Magnus P. Should radon be reduced in homes? A cost-effectiveness analysis. Health Phys. 2003;84(2):227-235.
33. Gagnon F, Courchesne M, Levesque B, et al. Assessment of the effectiveness of radon screening programs in reducing lung cancer mortality. Risk Anal. 2008;28(5):1221-1230.
34. Petersen ML, Larsen T. Cost-benefit analyses of radon mitigation projects. J Environ Manage. 2006;81 (1):19-26.
35. Denman AR, Phillips PS, Coskeran T, Groves-Kirby CJ, Crockett RGH, Tornberg R. Carefully targeted radon reduction strategies are more appropriate. BMJ; January 16, 2009. Available at: http://www.bmj.com/rapid-response/2011/11/ 02/carefully-targeted-radonreduction-strategies-are-more-appropriate. Accessed October 1, 2012.
36. Mendez D,Warner KE, Courant PN. Effects of radon mitigation vs. smoking cessation in reducing radonrelated risk of lung cancer. Am J Public Health. 1998; 88(5):811-812.
37. Zeeb H, ed. Report of the Second Meeting of the WHO International Radon Project. Geneva: World Health Organization; July 2006.
38. Lubin JH. Studies of radon and lung cancer in North America and China. Radiat Prot Dosimetry. 2003;104(4):315-319.
39. Hopkins DP, Razi S, Leeks KD, et al. Smokefree policies to reduce tobacco use. A systematic review. Am J Prev Med. 2010;38(2 suppl):S275-S289.
40. Cokkinides V, Bandi P, McMahon C, et al. Tobacco control in the United States-recent progress and opportunities. CA Cancer J Clin. 2009;59(6):352-365.
41. Davis RM, Wakefield M, Amos A, Gupta PC. The hitchhiker's guide to tobacco control: a global assessment of harms, remedies, and controversies. Annu Rev Public Health. 2007;28:171-194.
42. Lantz PM. Youth smoking prevention policy: lessons learned and continuing challenges. In: Bonnie RL, O'Connell ME, eds. Reducing Underage Drinking: A Collective Responsibility. Washington, DC: Institute of Medicine of the National Academies; 2004:716-742.
43. Fiore MC, Croyle RT, Curry SJ, et al. Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health. 2004;94(2):205-210.
44. Centers for Disease Control and Prevention. Best Practices for Comprehensive Tobacco Control Programs-2007. Atlanta: US Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2007.
45. World Health Organization. MPOWER: A Policy Package to Reverse the Tobacco Epidemic. Geneva; 2008.